Autoimmune Condition

When grappling with type 1 diabetes, the body faces a critical challenge: the inability to    produce any insulin whatsoever. This arises from a relentless assault by the immune system on the insulin-producing cells, leading to their destruction. As a result, type 1 diabetes earns its classification as an autoimmune condition, marking a distinct pathophysiological origin.In stark contrast, type 2 diabetes unfolds through a different narrative. Here, the body struggles to generate an adequate supply of insulin or encounters difficulties in its proper utilization. This intricate dance between insulin production and efficacy can stem from a myriad of factors, setting type 2 diabetes apart from its autoimmune counterpart.

    Related Conference of Autoimmune Condition

    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 13-14, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    November 27-28, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    November 27-28, 2024

    14th World Congress on Endocrinology and Diabetes

    Paris, France
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy

    Autoimmune Condition Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in